Recursion CEO on $688M Exscientia acquisition: Hope to bring better medicines to patients sooner

Поделиться
HTML-код
  • Опубликовано: 13 янв 2025

Комментарии • 10

  • @yusselfaveljl
    @yusselfaveljl 5 месяцев назад +7

    Sounds very optimistic and the potential seems tremendous. I hope the dream will become a reality. Good luck. 4:11

  • @buildingwhisper
    @buildingwhisper Месяц назад +2

    Dude absolutely loves the word absolutely

  • @kentschandorff6111
    @kentschandorff6111 4 месяца назад +1

    Exciting❤

  • @ronaldkrikorian4712
    @ronaldkrikorian4712 4 месяца назад +1

    If another drug fails at Recursion pharmaceutical then you have to dismiss your chief medical officer! Plain & Simple. Greetings from Australia 🇦🇺

  • @nikguitarocphone2505
    @nikguitarocphone2505 3 месяца назад +3

    stock down 50% since feb

  • @yusselfaveljl
    @yusselfaveljl 5 месяцев назад

    Is the system working yet? That is yet to be found out. Right now it's all speculation but I hope the speculation becomes reality.

  • @PatrickPerez-o1b
    @PatrickPerez-o1b 3 месяца назад

    Williams Scott Clark Richard Thompson Barbara

  • @InconspicuousOwl
    @InconspicuousOwl 2 месяца назад

    Rxrx 🚀 👩‍🚀 🚀 👨‍🚀 🚀 🦬